Erratum: Association between marijuana use and risk of cancer: A systematic review and meta-analysis (JAMA Network Open (2019) 2:11 (e1916318) DOI: 10.1001/jamanetworkopen.2019.16318);Association between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis

JAMA Network Open

Volumn 2, Issue 11, 2019, Pages

  Ghasemiesfe, Mehrnaz ^a,d   Barrow, Brooke ^b   Leonard, Samuel ^a   Keyhani, Salomeh ^c,d   Korenstein, Deborah ^e,f  

^a NC Inst for Research and Education   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; TETRAHYDROCANNABINOL;

BLADDER CANCER; BREAST CANCER; CANCER RISK; CANNABIS SMOKING; CANNABIS USE; COLORECTAL CANCER; ESOPHAGUS CANCER; GERM CELL CANCER; GLIOMA; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; KAPOSI SARCOMA; LARYNX CANCER; LUNG CANCER; MELANOMA; META ANALYSIS; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; MULTIPLE CANCER; NASOPHARYNX CARCINOMA; NON-SMOKER; NONHODGKIN LYMPHOMA; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT CANCER; UTERINE CERVIX CANCER; ADVERSE EVENT; NEOPLASM; RISK FACTOR;

HUMANS; MARIJUANA USE; NEOPLASMS; RISK FACTORS;

EID: 85075766439     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2019.21065     Document Type: Erratum

References (71)

1. Results from the 2017 National Survey on Drug Use and Health: detailed tables. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.htm. Accessed October 17, 2019.
2. National Institutes of Health. Prevalence of marijuana use among U.S. adults doubles over past decade [press release]. https://www.nih.gov/news-events/news-releases/prevalence-marijuana-use-among-us-adults-doubles-over-past-decade. Published October 21, 2015. Accessed October 17, 2019.
3. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators: National Survey on Drug Use and Health, United States, 2002-2014. MMWR Surveill Summ. 2016; 65 (11): 1-28. doi: 10.15585/mmwr.ss6511a1 27584586
4. Steigerwald S, Wong PO, Cohen BE, Smoking, vaping, and use of edibles and other forms of marijuana among US adults. Ann Intern Med. 2018; 169 (12): 890-892. doi: 10.7326/M18-1681 30167665
5. Hoffmann D, Brunnemann KD, Gori GB, On the carcinogenicity of marijuana smoke. In: Runeckles VC, ed. Recent Advances in Phytochemistry. Boston, MA: Springer-Verlag; 1975: 63-81. doi: 10.1007/978-1-4684-0823-2_3
6. Moir D, Rickert WS, Levasseur G, A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008; 21 (2): 494-502. doi: 10.1021/tx700275p 18062674
7. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988; 318 (6): 347-351. doi: 10.1056/NEJM198802113180603 3340105
8. 9-THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav. 1991; 40 (3): 657-661. doi: 10.1016/0091-3057(91)90378-F 1666924
9. Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002; 42 (S1): 71S-81S. doi: 10.1002/j.1552-4604.2002.tb06006.x 12412839
10. Heron M. Deaths: leading causes for 2016. https://stacks.cdc.gov/view/cdc/57988. Published July 26, 2018. Accessed October 17, 2019.
11. Lortet-Tieulent J, Goding Sauer A, Siegel RL, State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016; 176 (12): 1792-1798. doi: 10.1001/jamainternmed.2016.6530 27775761
12. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998; 90 (16): 1198-1205. doi: 10.1093/jnci/90.16.1198 9719080
13. Śledziński P, Zeyland J, Słomski R, Nowak A. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med. 2018; 7 (3): 765-775. doi: 10.1002/cam4.1312 29473338
14. Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int. 2018; 2018: _artnr 1691428. doi: 10.1155/2018/1691428 30627539
15. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151 (4): 264-269, W64. doi: 10.7326/0003-4819-151-4-200908180-00135 19622511
16. Blachly PH. Effects of decriminalization of marijuana in Oregon. Ann N Y Acad Sci. 1976; 282: 405-415. doi: 10.1111/j.1749-6632.1976.tb49913.x 1071391
17. IMS Institute for Healthcare Informatics. Global use of medicines: outlook through 2017. http://www.quotidianosanita.it/allegati/allegato1501906.pdf. Published November 2013. Accessed October 17, 2019.
18. Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote [published correction appears in J Med Libr Assoc. 2017;105(1):111]. J Med Libr Assoc. 2016; 104 (3): 240-243. doi: 10.3163/1536-5050.104.3.014 27366130
19. Wells GA, Shea B, O'Connell D, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Published 2014. Accessed September 29, 2017.
20. Paule RC, Mandel J. Consensus values and weighting factors. J Res Natl Bur Stand. 1982; 87: 377-385. doi: 10.6028/jres.087.022
21. Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001; 20 (24): 3875-3889. doi: 10.1002/sim.1009 11782040
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327 (7414): 557-560. doi: 10.1136/bmj.327.7414.557 12958120
23. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006; 25 (20): 3443-3457. doi: 10.1002/sim.2380 16345038
24. Berkman ND, Lohr KN, Ansari M, Grading the strength of a body of evidence when assessing health care interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: an update. Methods guide for comparative effectiveness reviews (prepared by the RTI-UNC Evidence-based Practice Center under contract 290-2007-10056-I). AHRQ publication 13(14)-EHC130-EF. Rockville, MD: Agency for Healthcare Research and Quality; November 2013. https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf. Accessed October 17, 2019.
25. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013; 24 (10): 1811-1820. doi: 10.1007/s10552-013-0259-0 23846283
26. Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997; 8 (5): 722-728. doi: 10.1023/A:1018427320658 9328194
27. Aldington S, Harwood M, Cox B,; Cannabis and Respiratory Disease Research Group. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J. 2008; 31 (2): 280-286. doi: 10.1183/09031936.00065707 18238947
28. Hashibe M, Morgenstern H, Cui Y, Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2006; 15 (10): 1829-1834. doi: 10.1158/1055-9965.EPI-06-0330 17035389
29. Zhang LR, Morgenstern H, Greenland S,; Cannabis and Respiratory Disease Research Group of New Zealand. Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015; 136 (4): 894-903. doi: 10.1002/ijc.29036 24947688
30. Berthiller J, Straif K, Boniol M, Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol. 2008; 3 (12): 1398-1403. doi: 10.1097/JTO.0b013e31818ddcde 19057263
31. Voirin N, Berthiller J, Benhaïm-Luzon V, Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol. 2006; 1 (6): 577-579. doi: 10.1097/01243894-200607000-00013 17409920
32. Han B, Gfroerer JC, Colliver JD. Associations between duration of illicit drug use and health conditions: results from the 2005-2007 National Surveys on Drug Use and Health. Ann Epidemiol. 2010; 20 (4): 289-297. doi: 10.1016/j.annepidem.2010.01.003 20171900
33. Gillison ML, D'Souza G, Westra W, Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100 (6): 407-420. doi: 10.1093/jnci/djn025 18334711
34. Liang C, McClean MD, Marsit C, A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila). 2009; 2 (8): 759-768. doi: 10.1158/1940-6207.CAPR-09-0048 19638490
35. Aldington S, Harwood M, Cox B,; Cannabis and Respiratory Disease Research Group. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg. 2008; 138 (3): 374-380. doi: 10.1016/j.otohns.2007.12.002 18312888
36. Zhang ZF, Morgenstern H, Spitz MR, Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999; 8 (12): 1071-1078. 10613339
37. Feng BJ, Khyatti M, Ben-Ayoub W, Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer. 2009; 101 (7): 1207-1212. doi: 10.1038/sj.bjc.6605281 19724280
38. Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res. 2004; 64 (11): 4049-4054. doi: 10.1158/0008-5472.CAN-03-3425 15173020
39. Llewellyn CD, Johnson NW, Warnakulasuriya KAAS. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med. 2004; 33 (9): 525-532. doi: 10.1111/j.1600-0714.2004.00222.x 15357672
40. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004; 40 (3): 304-313. doi: 10.1016/j.oraloncology.2003.08.015 14747062
41. Thomas AA, Wallner LP, Quinn VP, Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study. Urology. 2015; 85 (2): 388-392. doi: 10.1016/j.urology.2014.08.060 25623697
42. Lacson JCA, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012; 118 (21): 5374-5383. doi: 10.1002/cncr.27554 22965656
43. Trabert B, Sigurdson AJ, Sweeney AM, Strom SS, McGlynn KA. Marijuana use and testicular germ cell tumors. Cancer. 2011; 117 (4): 848-853. doi: 10.1002/cncr.25499 20925043
44. Daling JR, Doody DR, Sun X, Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009; 115 (6): 1215-1223. doi: 10.1002/cncr.24159 19204904
45. Chacko JA, Heiner JG, Siu W, Macy M, Terris MK. Association between marijuana use and transitional cell carcinoma. Urology. 2006; 67 (1): 100-104. doi: 10.1016/j.urology.2005.07.005 16413342
46. Maden C, Sherman KJ, Beckmann AM, History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993; 85 (1): 19-24. doi: 10.1093/jnci/85.1.19 8380060
47. Chao C, Jacobson LP, Jenkins FJ, Recreational drug use and risk of Kaposi's sarcoma in HIV-and HHV-8-coinfected homosexual men. AIDS Res Hum Retroviruses. 2009; 25 (2): 149-156. doi: 10.1089/aid.2008.0196 19108691
48. Efird JT, Friedman GD, Sidney S, The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004; 68 (1): 57-69. doi: 10.1023/B:NEON.0000024746.87666.ed 15174522
49. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol. 1999; 150 (4): 375-389. doi: 10.1093/oxfordjournals.aje.a010017 10453814
50. Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006; 166 (13): 1359-1367. doi: 10.1001/archinte.166.13.1359 16832000
51. Martinasek MP, McGrogan JB, Maysonet A. A systematic review of the respiratory effects of inhalational marijuana. Respir Care. 2016; 61 (11): 1543-1551. doi: 10.4187/respcare.04846 27507173
52. de Carvalho MFF, Dourado MR, Fernandes IB, Araújo CT, Mesquita AT, Ramos-Jorge ML. Head and neck cancer among marijuana users: a meta-analysis of matched case-control studies. Arch Oral Biol. 2015; 60 (12): 1750-1755. doi: 10.1016/j.archoralbio.2015.09.009 26433192
53. Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015; 15 (1): 897. doi: 10.1186/s12885-015-1905-6 26560314
54. Gandhi S, Vasisth G, Kapoor A. Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers. Can Urol Assoc J. 2017; 11 (3-4): E138-E142. doi: 10.5489/cuaj.4371 28515817
55. Rajanahally S, Raheem O, Rogers M, The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology. 2019; 7 (2): 139-147. doi: 10.1111/andr.12585 30767424
56. Sarafian TA, Magallanes JAM, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke: an adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol. 1999; 20 (6): 1286-1293. doi: 10.1165/ajrcmb.20.6.3424 10340948
57. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998; 157 (3, pt 1): 928-937. doi: 10.1164/ajrccm.157.3.9701026 9517614
58. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997; 112 (2): 319-326. doi: 10.1378/chest.112.2.319 9266864
59. Kaufman DW, Palmer JR, Rosenberg L, Stolley P, Warshauer E, Shapiro S. Tar content of cigarettes in relation to lung cancer. Am J Epidemiol. 1989; 129 (4): 703-711. doi: 10.1093/oxfordjournals.aje.a115185 2923118
60. Yoshie Y, Ohshima H. Synergistic induction of DNA strand breakage by cigarette tar and nitric oxide. Carcinogenesis. 1997; 18 (7): 1359-1363. doi: 10.1093/carcin/18.7.1359 9230280
61. Zang EA, Wynder EL. Cumulative tar exposure: a new index for estimating lung cancer risk among cigarette smokers. Cancer. 1992; 70 (1): 69-76. doi: 10.1002/1097-0142(19920701)70:1<69::AID-CNCR2820700112>3.0.CO;2-A 1606549
62. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health. 1987; 77 (4): 425-431. doi: 10.2105/AJPH.77.4.425 3826460
63. Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products: regulations in Europe and North America. Eur J Intern Med. 2018; 49: 2-6. doi: 10.1016/j.ejim.2018.01.001 29329891
64. Trivers KF, Phillips E, Gentzke AS, Tynan MA, Neff LJ. Prevalence of cannabis use in electronic cigarettes among US youth. JAMA Pediatr. 2018; 172 (11): 1097-1099. doi: 10.1001/jamapediatrics.2018.1920 30242366
65. Borodovsky JT, Lee DC, Crosier BS, Gabrielli JL, Sargent JD, Budney AJ. U.S. cannabis legalization and use of vaping and edible products among youth. Drug Alcohol Depend. 2017; 177: 299-306. doi: 10.1016/j.drugalcdep.2017.02.017 28662974
66. Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction. 2015; 110 (11): 1699-1704. doi: 10.1111/add.13036 26264448
67. Eng CH, Yu K, Lucas J, White E, Abraham RT. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal. 2010; 3 (119): ra31. doi: 10.1126/scisignal.2000911 20424262
68. Bloor RN, Wang TS, Španěl P, Smith D. Ammonia release from heated "street" cannabis leaf and its potential toxic effects on cannabis users. Addiction. 2008; 103 (10): 1671-1677. doi: 10.1111/j.1360-0443.2008.02281.x 18705690
69. Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science. 2017; 358 (6365): 941-946. doi: 10.1126/science.aam9305 29025995
70. FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer [press release]. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm583295.htm. Published November 1, 2017. Accessed October 17, 2019.
71. Shi S, Brant AR, Sabolch A, Pollom E. False news of a cannabis cancer cure. Cureus. 2019; 11 (1): _artnr e3918. doi: 10.7759/cureus.3918 30931189